No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine

Pakpoor, J, Disanto, G, Altmann, DR et al. (7 more authors) (2015) No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine. Neuroimmunology & Neuroinflammation, 2 (6). 158. e158 - e158.

Abstract

Metadata

Authors/Creators:
  • Pakpoor, J
  • Disanto, G
  • Altmann, DR
  • Pavitt, SH
  • Turner, BP
  • Marta, M
  • Juliusson, G
  • Baker, D
  • Chataway, J
  • Schmierer, K
Copyright, Publisher and Additional Information: This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially
Dates:
  • Published: December 2015
  • Accepted: 5 August 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Dentistry (Leeds) > Dentistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Oct 2015 09:10
Last Modified: 05 Oct 2015 09:10
Published Version: http://dx.doi.org/10.1212/NXI.0000000000000158
Status: Published
Publisher: Wolters Kluwer Health/LWW
Identification Number: https://doi.org/10.1212/NXI.0000000000000158

Share / Export

Statistics